Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

10 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Clinical activity and safety of combination therapy with temsirolimus and bevacizumab for advanced melanoma: a phase II trial (CTEP 7190/Mel47).
Slingluff CL Jr, Petroni GR, Molhoek KR, Brautigan DL, Chianese-Bullock KA, Shada AL, Smolkin ME, Olson WC, Gaucher A, Chase CM, Grosh WW, Weiss GR, Wagenseller AG, Olszanski AJ, Martin L, Shea SM, Erdag G, Ram P, Gershenwald JE, Weber MJ. Slingluff CL Jr, et al. Among authors: molhoek kr. Clin Cancer Res. 2013 Jul 1;19(13):3611-20. doi: 10.1158/1078-0432.CCR-12-3919. Epub 2013 Apr 25. Clin Cancer Res. 2013. PMID: 23620404 Free PMC article. Clinical Trial.
VEGFR-2 expression in human melanoma: revised assessment.
Molhoek KR, Erdag G, Rasamny JK, Murphy C, Deacon D, Patterson JW, Slingluff CL Jr, Brautigan DL. Molhoek KR, et al. Int J Cancer. 2011 Dec 15;129(12):2807-15. doi: 10.1002/ijc.25963. Epub 2011 May 5. Int J Cancer. 2011. PMID: 21544800 Free PMC article.
Evaluation of molecular markers of mesenchymal phenotype in melanoma.
Mikesh LM, Kumar M, Erdag G, Hogan KT, Molhoek KR, Mayo MW, Slingluff CL Jr. Mikesh LM, et al. Among authors: molhoek kr. Melanoma Res. 2010 Dec;20(6):485-95. doi: 10.1097/CMR.0b013e32833fafb4. Melanoma Res. 2010. PMID: 20856146 Free PMC article.